arecoline has been researched along with 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brand, A; Hawdon, JM | 1 |
| Chang, YC; Huang, FM; Lee, SS; Tsai, CH | 1 |
2 other study(ies) available for arecoline and 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one
| Article | Year |
|---|---|
Phosphoinositide-3-OH-kinase inhibitor LY294002 prevents activation of Ancylostoma caninum and Ancylostoma ceylanicum third-stage infective larvae.
Topics: Ancylostoma; Animals; Arecoline; Blotting, Western; Chromones; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Enzyme Inhibitors; Insulin; Larva; Morpholines; Muscarinic Agonists; Phosphoinositide-3 Kinase Inhibitors; Signal Transduction | 2004 |
Regulation of protease-activated receptor-1 expression in human buccal fibroblasts stimulated with arecoline.
Topics: Acetylcysteine; Arecoline; Blotting, Western; Cell Culture Techniques; Cholinergic Agonists; Chromones; Enzyme Inhibitors; Fibroblasts; Flavonoids; Humans; Immunohistochemistry; Morpholines; Mouth Mucosa; Nitrobenzenes; Oral Submucous Fibrosis; Receptor, PAR-1; Rifabutin; Sulfonamides | 2013 |